The hypothesis that substrate availability can alter contractile function in reperfused myocardium after global ischemia was investigated in this study. Isolated rabbit hearts were placed in a dual tuned C'PI13C) NMR probe with a 9.4-T magnet and perfused with the following substrates given individually or in combination: 10 mM glucose, 2 mM palmitate, and 2.5 mM [3-13C] 
The hypothesis that substrate availability can alter contractile function in reperfused myocardium after global ischemia was investigated in this study. Isolated rabbit hearts were placed in a dual tuned C'PI13C) NMR probe with a 9.4-T magnet and perfused with the following substrates given individually or in combination: 10 mM glucose, 2 mM palmitate, and 2.5 mM [3-13C] pyruvate.
Glucose was the sole substrate present for all groups of hearts before the onset of 10 or 20 minutes of zero-flow ischemia. Contractility (dP/dt) was significantly higher in hearts reperfused with glucose compared with hearts reperfused with palmitate or the combination. In addition, myocardial oxygen consumption/unit of work at reperfusion was more efficient with glucose than with palmitate. ATP content during reperfusion was similar with glucose and palmitate and did not account for improved function with glucose. To ith the advent of thrombolytic therapy for the treatment of acute myocardial infarction, attention has been directed to possible therapeutic interventions that may enhance the mechanical performance of reperfused myocardium. 1 The beneficial effects derived from various interventions generally have been attributed to a reduction in the cell injury produced by ischemia or the prevention of further injury caused by reperfusion. A number of different types of pharmacological interventions have been studied, including fl-blockade and calcium channel blockade and the use of free radical scavengers. ' Other studies have examined the role of substrate metabolism and its effects on cardiac performance. For example, long-chain fatty acids have been shown to impair left ventricular function and cause ventric-ular arrhythmias in humans.2 Perfusion of isolated rat hearts with palmitate before the induction of global ischemia produced a greater reduction in left ventricular function during ischemia than did perfusion of hearts under similar conditions with glucose or a lower concentration of fatty acid. 3 Studies in the isolated, in situ swine heart model during regional myocardial hypoperfusion demonstrated a decrease in cardiac contractility in association with an increase in tissue acyl coenzyme A and acylcarnitine. 4 The rise in tissue amphiphiles suggested the possibility that long-chain fatty acid metabolites may contribute to ischemic myocardial dysfunction during hypoperfusion. Indeed, inhibition of fatty acid metabolism with the palmitoylcarnitine transferase I inhibitor oxfenicine reduced the amphiphile concentration and improved function.5 However, with reperfusion, cardiac function was largely unaffected by an increase in myocardial amphiphiles. 6, 7 It has been clearly established that long-chain fatty acids, when present in high concentrations, are the preferred substrate metabolized by normal8 and reperfused myocardium.6,9 Fatty acid metabolism in-hibits the pyruvate dehydrogenase complex by a direct feedback effect on the active form of the enzyme.10 Studies of normal hearts have demonstrated that fatty acids inhibit glucose transport in the cell,'1 as well as phosphofructokinase and glucose phosphorylation through an increase in citrate.1213 Positron emission tomography studies of reperfused myocardium have demonstrated delayed [`C]palmitate clearance in association with an increase in ['8Fldeoxyglucose uptake.'4 These findings are consistent with a shift in substrate utilization from palmitate to glucose. However, Myears et al15 found that despite a doubling in [3H]glucose uptake in the reperfused myocardium, much of the substrate was not immediately used for energy production. A small increase in anaerobic metabolism was noted in the reperfused myocardium, but most of the energy produced was derived from palmitate. The authors postulated that enhanced membrane transport of glucose and repletion of glycogen might account for the increase in glucose uptake observed with positron emission tomography. Lopaschuk et a19 showed that by inhibiting palmitate metabolism with the carnitine palmitoyltransferase I inhibitor etomoxir, glucose oxidation was increased and contractile function was improved in the reperfused myocardium. 9 Renstrom et al16 found a twofold increase in glucose oxidation in reperfused myocardium when oxfenicine, a carnitine palmitoyltransferase I inhibitor, was given to the in situ swine heart preparation. 16 Enhanced glucose oxidation was associated with a significant improvement in cardiac function during hypoperfusion but not during reperfusion. In both of these studies it was apparent that the switch to glucose utilization by the reperfused myocardium could be elicited only if inhibitors of long-chain fatty acid metabolism were used. The investigation of glucose utilization by nonoxidative and oxidative pathways was not attempted in these studies.
Previous studies have demonstrated the utility of NMR spectroscopy for the direct study of The present study was undertaken to determine 1) if the availability of physiologically relevant fatty acids, in particular palmitate, could alter cardiac function in the isolated perfused rabbit heart after global ischemia; 2) if altered contractile function might be caused by changes in high energy phosphate content; and 3) if regulation of oxidative pyruvate utilization by palmitate alters postischemic myocardial function. To achieve these goals, high energy phosphate content and pyruvate oxidation in the presence of palmitate were examined with NMR spectroscopy.
Materials and Methods Dutch-belted rabbits (500-750 g) were anesthetized with an intraperitoneal injection of pentobarbital sodium (200 mg/kg). The study was approved by the Subcommittee for Animal Use of Baylor College of Medicine and conforms to the position of the American Heart Association on research animal use. The heart was removed at the ascending aorta through a midsternal incision and immediately washed with ice-cold cardioplegic solution (120 mM NaCl+30 mM KCI). The heart was retrogradely perfused at a constant pressure of 100 cm water with a modified Krebs-Henseleit buffer (116 mM NaCl, 4 mM KCI, 1.5 mM CaCl2, 1.2 mM MgSO4, 1.2 mM NaH2PO4, 25 mM NaHCO3). The buffer was gassed with 95% 02-5% CO2 and maintained at 37°C at the level of the aortic cannula. No insulin was added to the perfusate. Perfusate supply was circulated from a 2-1 reservoir containing 5 mM glucose. A catheter was placed into the pulmonary artery to collect coronary effluent. Myocardial oxygen consumption (MVo2) was determined as previously described.23 A water-filled latex balloon was attached to a pressure transducer and inserted into the left ventricle through the left atrium to measure developed pressure and contractility (dP/dt). Volume in the latex balloon was increased to achieve an end-diastolic pressure of approximately 10 mm Hg. All data were recorded on a physiological monitoring system (model 2400S, Gould, Cleveland). The reservoir was enclosed in a heating pad, and temperature was held constant with a temperature-controlling device (model 2157, Cole Palmer, Chicago). The heart preparation was contained in a 20-mm glass tube and placed inside the bore of the magnet. To switch the substrate provided to the heart, a stopcock was turned to direct perfusate from the larger reservoir to a smaller (400 ml) reservoir. Since albumin was shown to cause a slight decrease in dP/dt and rate/ pressure product in a preliminary study (high energy phosphates were unchanged in the preliminary study), all substrates were combined with 0.67 mM albumin. Oxygenation was achieved without foaming by continuously circulating the perfusate through an oxygenated glass chamber designed to distribute the fluid over a large surface area. The fluid was also oxygenated by passing it through gas-permeable Silastic tubing held within a Tygon oxygen jacket enroute to the heart. With this technique, Po2 of the perfusate was >400 mm Hg. NMR 
Spectroscopy
The heart preparation was situated within a 20 mm, 31P/'3C-tuned NMR probe (Bruker Instruments, Inc., Billerica, Mass.). NMR data were acquired using a wide-bore AM 400 spectrometer (Bruker) equipped with an Aspect 3000 series computer and a superconducting magnet (9.4 T). The sample chamber was tuned and the field homogeneity optimized using the proton signal of water. The probe was maintained at 37°C throughout the study. A composite 13C-free induction decay was acquired at 100.6 MHz in 6 minutes (180 acquisitions) using a 450 pulse angle and a 2-second repetition time. Sample heating was prevented by power-gating the broadband proton decoupling (0.5-5 W). To eliminate background 13C signal, naturally abundant`3C was obtained before 13C enrichment and then digitally subtracted from subsequent spectral data. Frequency induction decays were zero-filled to improve digital resolution, and exponential multiplication was performed to enhance the signal-to-noise ratio. Frequency domain spectra were produced by Fourier transformation. Peak assignments were made with reference to dioxane at 67.4 ppm. Pulse parameters were selected to prevent partial saturation of the resonances. 24 Separate`3C spectra were acquired of heart extracts with and without inverse-gated decoupling to correct for contributions of nuclear overhauser enhancement to signal intensity. 31p spectra were obtained at 162 MHz over 2 minutes (60 acquisitions) with a 450 pulse angle and a 2-second repetition time. An exponential function was introduced to improve signal-to-noise ratio. After Fourier transformation, resonance peak assignments were made relative to phosphocreatine (PCr) at 0 ppm. Relative ATP levels were determined from the signal intensity of the /3-phosphate peak.
Protocol
To ensure that conditions were similar before and during ischemia, all hearts were perfused with 5 mM glucose as the sole substrate until the time of reperfusion. Two sets of experiments were performed; one involved the use of glucose and palmitate and the other involved the use of palmitate and pyruvate. All groups consisted of at least six hearts. Palmitate/glucose reperfusion. Hearts were perfused from the 2-1 reservoir until developed pressure and dP/dt were stable. After 20 minutes of ischemia, reperfusion was begun from a 400-ml reservoir containing one of the following substrates or substrate combinations: glucose (10 mM), palmitate (2 mM), or palmitate/glucose (2 mM/10 mM). To ensure that simply changing perfusion to a different reservoir did not contribute to a change in the performance of the preparation, some hearts were perfused successively with 5 mM glucose from the 2-1 and the 400-ml reservoir Figure 7A shows the changes in the percent maximum [4- Palmitate/pyruvate reperfusion. The bottom portion of Figure 7C describes the changes in TCA cycle flux associated with the addition of palmitate to the perfusate. Palmitate had no effect on the [2-'3C]GLU/ [4- 3C]GLU ratio. Thus, the effect of palmitate on control and reperfused hearts was to decrease pyruvate utilization without an effect on TCA cycle activity.
Lactate Measurements
A large quantity of lactate washed out in the first 5 minutes of reperfusion in both the glucose-and palmitate-reperfused hearts (Table 1) . Lactate content in the coronary effluent thereafter remained low in both groups and no differences occurred between the two substrates. These findings were consistent with intact (although delayed) oxidative utilization of pyruvate by the reperfused myocardium. T-_ 4/ / 4 T T.
Percent maximum (% max) [4- in the present study and the lack of supplemental glucose in the perfusate most likely accounted for the lack of a significant inotropic effect from pyruvate.
In the present study, ATP content was significantly reduced at 9 and 19 minutes of ischemia. The uniformity of reduction in ATP content was a reflection of the fact that all hearts were made globally ischemic during glucose perfusion. The pertinent finding of this study was that ATP content remained below baseline throughout the reperfusion period and was not significantly affected by substrate availability. In contrast to these findings, Lopaschuk et a17 found that a decrease in ATP produced by 25 minutes of global ischemia was partially reversed in hearts reperfused with glucose but not with palmitate. In their study, palmitate was present in the perfusate during ischemia as well as reperfusion, whereas in the current study, palmitate was present only at reperfusion. Since contrast to the relatively high MVo2 at the end of reperfusion. The data obtained in this study do not provide further explanation of this phenomenon, which has previously been observed in our laboratory.22 However, reduced pyruvate oxidation has been observed in the reperfused working swine heart,36 while oxygen wasting relative to contractility has been reported in reperfused myocardium. 6, 38 The observation in the present study that lactate release was low during reperfusion indicated that significant latent postischemic hypoxia was absent during reperfusion. Although we demonstrated that oxidative metabolism was slowed in the reperfused myocardium, the absence of continued high lactate release indicates that there was no large scale shift toward anaerobic metabolism during reperfusion. These data also indicate that the redox state within the reperfused myocardium was maintained at approximately control levels.
In summary, we have shown in this study that palmitate, when given only during reperfusion after reversible global ischemia in the isolated rabbit heart, was less effective than glucose in enhancing contractile recovery. Palmitate reperfusion was not associated with a reduction in high energy phosphate content, which bore no relation to the various de-grees of contractile dysfunction observed in this study. Palmitate reduced pyruvate utilization in control and reperfused hearts, probably by inhibiting pyruvate dehydrogenase. However, this reduction of pyruvate metabolism had no effect on function in the reperfused myocardium.
